Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-17-002467

Options or other derivatives

  • Director acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TRAVERSA SERGIO Director 2017-03-14 Grant or award · Options to purchase common stock +75,000 $1.39 $104,250 75,000 D
Loading xslF345X03/f4031417traversa_actinium.xml…